{
  "id": 4310355,
  "title": "Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?",
  "url": "https://urgent.news/2026/08/29/has-novo-nordisk-finally-found-the-catalyst-that-could-flip-the-4310355",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-29T23:35:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/has-novo-nordisk-finally-found-catalyst-could-flip-script-eli-lilly"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsNovo Nordisk was first with a GLP-1 weight-loss shot, but lost the lead to Eli Lilly.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?",
        "url": "https://urgent.news/2026/08/29/has-novo-nordisk-finally-found-the-catalyst-that-could-flip-the",
        "published": "2026-08-29T23:15:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}